38956-79-5 Usage
Description
3-Methylpyridazin-6-ylhydrazine is an organic compound with the molecular formula C5H6N4. It is a heterocyclic compound featuring a pyridazine ring with a methyl group at the 3rd position and a hydrazine group at the 6th position. 3-Methylpyridazin-6-ylhydrazine serves as an important intermediate in the synthesis of various pharmaceuticals and chemical compounds due to its unique structural properties.
Uses
Used in Pharmaceutical Industry:
3-Methylpyridazin-6-ylhydrazine is used as a key intermediate in the synthesis of GPR139 receptor modulators, specifically for the preparation of 2-(3-oxo-2H,3H-[1,2,4]triazolo[4,3-b]pyridazin-2-yl)acetamide and 2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl)acetamide derivatives. These modulators play a crucial role in targeting the GPR139 receptor, which is associated with the regulation of dopamine and has potential therapeutic applications in treating neurological disorders such as schizophrenia, Parkinson's disease, and addiction.
Check Digit Verification of cas no
The CAS Registry Mumber 38956-79-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,9,5 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 38956-79:
(7*3)+(6*8)+(5*9)+(4*5)+(3*6)+(2*7)+(1*9)=175
175 % 10 = 5
So 38956-79-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H8N4/c1-4-2-3-5(7-6)9-8-4/h2-3H,6H2,1H3,(H,7,9)
38956-79-5Relevant articles and documents
BICYCLIC TRIAZOLES AS PROTEIN KINASE MODULATORS
-
Page/Page column 107, (2008/12/05)
The present disclosure provides bicyclic triazole protein kinase modulators and methods of using these compounds to treat diseases mediated by kinase activity.
Hydrazination of Pyridazines and Phthalazines
Counotte-Potman, A.,Plas, H. C. van der
, p. 1259 - 1261 (2007/10/02)
It is shown by 15N-labelling techniques that hydrazination of pyridazines partly occurs according to a reaction pathway, involving addition of the nucleophile (hydrazine), ring opening and ring closure (SN(ANRORC)-mechanism).It is also proved that phthalazines undergo hydrazination without ring opening (SN(AE)-mechanism).
